CCM
GILD icon

Capstone Capital Management’s Gilead Sciences GILD Stock Holding History

Capstone Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$802K Buy
+6,345
New +$836K 0.36% 84
2026
Q1 		– Sell
-6,459
Closed -$793K – 73
2025
Q4 		$793K Buy
+6,459
New +$785K 0.76% 46

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capstone Capital Management's GILD Position: Q2 2026 in Review

Capstone Capital Management opened a new position in Gilead Sciences (GILD) in Q2 2026: 6,345 shares worth $802K. The stake represents 0.36% of the portfolio and ranks #84 among its holdings. This is a return to the name: Capstone Capital Management previously reported a position in GILD as recently as Q4 2025.

Capstone Capital Management first reported a position in GILD in Q4 2025 and has held it in 2 quarters since. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Capstone Capital Management held 6,345 shares of Gilead Sciences worth $802K as of Q2 2026.
  • Gilead Sciences was a new Capstone Capital Management position in Q2 2026.
  • Gilead Sciences made up 0.36% of Capstone Capital Management's portfolio in Q2 2026, its #84 holding.
  • Capstone Capital Management first reported a position in Gilead Sciences in Q4 2025 and has held it in 2 quarters since.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Capstone Capital Management's 13F filing for Q2 2026, filed 20 Jul 2026.